75.89
5.89 (8.41%)
| Penutupan Terdahulu | 70.00 |
| Buka | 72.50 |
| Jumlah Dagangan | 17,725 |
| Purata Dagangan (3B) | 41,373 |
| Modal Pasaran | 246,283,616 |
| Harga / Jualan (P/S) | 10.75 |
| Harga / Buku (P/B) | 10.65 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 1 May 2026 |
| Margin Keuntungan | -107.77% |
| Margin Operasi (TTM) | -879.63% |
| EPS Cair (TTM) | -4.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 121.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.84% |
| Nisbah Semasa (MRQ) | 5.12 |
| Aliran Tunai Operasi (OCF TTM) | -13.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.91 M |
| Pulangan Atas Aset (ROA TTM) | -26.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -49.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Sol-Gel Technologies Ltd. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.13 |
|
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 70.00% |
| % Dimiliki oleh Institusi | 24.29% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |